Call for Abstracts: 2nd German Mass Cytometry User Forum in Berlin
Extended deadline for abstract submissions: November 28, 2018
Extended deadline for abstract submissions: November 28, 2018
Ipsen (Euronext: IPN; ADR: IPSEY) and 3BP today announced the first patient has been dosed in a Phase I/II study for the first-in-class radionuclide 177Lu-IPN01087 (formerly known as 3BP-227). IPN01087 is a compound that targets cancer cells in…
Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in isotope-related applications in medicine, science and industry, increased the earnings per share to €2.50 in the third quarter of 2018 and thus reached…
NOXXON ends the use of variable rate equity financing with Yorkville
A new Research Training Group aims to decode the complex structure of peptides. The German Research Foundation is to provide EUR 4.5 million in funding for the research
R2R Biofluidics EU project recently received the Austrian Fast Forward Award 2018
Proceeds provide OMEICOS with the financial runway to conduct the Phase II Study PROMISE-AF and continue expansion into ophthalmology through US subsidiary
ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins announced today that it has completed a cell line development project for one of Zymeworks Inc.’s bispecific antibody program which exceeded…
Forbion invests €12.5m from its recently launched Forbion IV fund
OMEICOS is pioneering the development of stable analogs of omega-3 fatty acid metabolites for Cardiovascular Disease and Ophthalmology
Forbion, a leading European life science…
Eyeluminati from India chosen out of 60 applications from 19 countries